inhibitory glp 1 GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Cardiorenal Protection: Potential of SGLT2
Description
The important thing is to pay close attention to how your body is changing
Currently, nearly 100 million people globally are affected by DR, and as the prevalence of diabetes continues to rise, this number is expected to grow, posing a significant burden on public health (82)
Recent Prog Horm Res
The GLP-1 meal plan focuses on nutrition education and portion control to promote healthy changes
Recent trial evidence also suggests a beneficial effect of GLP-1 RA use on diabetic renal disease [167], which supports signals observed in the early GLP-1 trials [9]
Secondly, there is a lack of uniformity in the efficacy evaluation methods employed across studies
